Expert Rev Hematol 2018 04 26;11(4):337-349. Epub 2018 Feb 26.
d Division of Hematology , Stanford University School of Medicine , Stanford , CA , USA.
Background: 7 regimens of pentostatin based chemoimmunotherapy (CIT) for progressive previously untreated CLL primarily with long term follow-up to update both efficacy and toxicity.
Research Design And Methods: Prognostic markers including assessment of IGVH and FISH status were done on all. Response rates and 95% binomial confidence intervals were calculated for each regimen and in the combined cohort. Read More